| Breakdown | TTM | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 371.11B | 386.54B | 366.64B | 340.83B | 316.85B | 311.59B |
| Gross Profit | 64.46B | 66.70B | 63.52B | 50.00B | 44.67B | 49.91B |
| EBITDA | 25.52B | 24.31B | 24.41B | 15.05B | 11.96B | 17.27B |
| Net Income | 16.48B | 16.16B | 15.78B | 8.94B | 5.24B | 10.28B |
Balance Sheet | ||||||
| Total Assets | 222.27B | 215.66B | 228.66B | 210.00B | 198.45B | 194.15B |
| Cash, Cash Equivalents and Short-Term Investments | 126.76B | 118.47B | 136.58B | 120.95B | 118.16B | 123.53B |
| Total Debt | 2.23B | 0.00 | 10.00M | 4.00M | 4.00M | 19.00M |
| Total Liabilities | 88.73B | 99.30B | 94.91B | 88.39B | 83.16B | 80.73B |
| Stockholders Equity | 133.53B | 116.35B | 133.75B | 121.61B | 115.29B | 113.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.41B | 21.11B | 17.31B | 8.13B | 2.15B |
| Operating Cash Flow | 0.00 | 19.57B | 22.71B | 18.18B | 8.95B | 2.94B |
| Investing Cash Flow | 0.00 | -3.92B | -3.73B | -3.98B | -241.00M | -1.29B |
| Financing Cash Flow | 0.00 | -33.75B | -3.37B | -3.37B | -3.40B | -2.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥168.19B | 9.33 | ― | 2.33% | 5.43% | 5.50% | |
66 Neutral | ¥194.75B | 13.30 | 20.50% | 1.49% | 3.01% | -18.79% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | ¥186.49B | 10.50 | 16.39% | 2.38% | 11.56% | 14.99% | |
61 Neutral | ¥113.90B | 7.26 | 15.81% | 2.93% | 12.51% | 12.42% | |
57 Neutral | ¥63.22B | 9.42 | ― | 2.89% | 4.32% | 11.25% | |
52 Neutral | ¥39.83B | 21.46 | ― | 0.45% | 23.11% | 8.31% |